Tissue dissociation enzyme,Tissue digestion,Recombinant collagenase,Collagenase G & collagenase H,islet isolation,adipose derived stem cell,ADSC isolation,Dupuytren's contracture therapeutics,Peyronie's Disease therapeutics,Cellulite therapeutics,Recombinant thermolysin,Wound debridement

TDzyme brochure - Korean version > resources

본문 바로가기
  • New Standard of
    Tissue Dissociation Enzyme

    TDzyme®

    Recombinant tissue dissociation enzymes
    individually contained in a smart device

Brochure TDzyme brochure - Korean version

페이지 정보

댓글 0Count 조회 939Count 작성일 20-04-01 15:36

본문

The attached is a Korean version of TDzyme brochure.

댓글목록

There are no registered comments.

CONNEXT is a spin-off company of Korea Institute of Industrial Technology (KITECH), a Korean government funded
research institute, offering highly purified recombinant proteins in a smart device for tissue engineering,
cell isolation and primary cell research field.

Founded in 2017, Connext is a Korean clinical-stage biotechnology company spun-off from a
government-funded research institute. Connext aims to improve quality of life by rapidly delivering
innovative medicines and technologies to patients. Based on its current portfolio, TLR5 agonist and
collagenase, Connext is expanding indications to cover a wide range of diseases in the areas of
oncology, dermatology and chronic wound care. To achieve this, Connext is focused on finding
opportunities to connect and collaborate with partners globally.